R
Reviva Pharmaceuticals Holdings D
D
RVPH
1.27500
USD
0.27
(26.24%)
مفتوح الان
حجم التداول
136,229
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
42,194,284
المقالات
العنوان: Reviva Pharmaceuticals Holdings
القطاع: Healthcare
الصناعة: Biotechnology
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which isintended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.